Research programme: anti-fungals - MycoLogics
Alternative Names: Anti-fungals research programme - MycoLogicsLatest Information Update: 13 Jan 2003
At a glance
- Originator MycoLogics; Nonindustrial source
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 13 Jan 2003 No development reported - Preclinical for Mycoses in USA (unspecified route)
- 10 Oct 2000 Preclinical development for Mycoses in USA (Unknown route)